Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis
- PMID: 34092973
- PMCID: PMC8160621
- DOI: 10.3748/wjg.v27.i20.2521
Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis
Abstract
Inflammatory bowel disease, encompassing Crohn's disease (CD) and ulcerative colitis, are chronic immune-mediated inflammatory bowel diseases (IBD) that primarily affect the gastrointestinal tract with periods of activity and remission. Large body of evidence exist to strengthen the prognostic role of endoscopic evaluation for both disease activity and severity and it remains the gold standard for the assessment of mucosal healing. Mucosal healing has been associated with improved clinical outcomes with prolonged remission, decreased hospitalization, IBD-related surgeries and colorectal cancer risk. Therefore, endoscopic objectives in IBD have been incorporated as part of standard care. With the known increased risk of colorectal cancer in IBD, although prevention strategies continue to develop, regular surveillance for early detection of neoplasia continue to be paramount in IBD patients' care. It is thanks to evolving technology and visualization techniques that surveillance strategies are continuously advancing. Therapeutic endoscopic options in IBD have also been expanding, from surgery sparing therapies such as balloon dilation of fibrostenotic strictures in CD to endoscopic mucosal resection of neoplastic lesions. In this review article, we discuss the current evidence on the use of endoscopy as part of standard of care of IBD, its role in surveillance of neoplasia, and the role of interventional endoscopic therapies.
Keywords: Crohn’s disease; Endoscopy; Inflammatory bowel disease; Surveillance; Therapeutic endoscopy; Ulcerative colitis.
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: Rubin DT has received grant support from Takeda; and has served as a consultant for Abbvie, Altrubio, Allergan Inc., Arena Pharmaceuticals, Bellatrix Pharmaceuticals, Boehringer Ingelheim Ltd., Bristol-Myers Squibb, Celgene Corp/Syneos, Connect BioPharma, GalenPharma/Atlantica, Genentech/Roche, Gilead Sciences, InDex Pharmaceuticals, Ironwood Pharmaceuticals, Iterative Scopes, Janssen Pharmaceuticals, Lilly, Materia Prima, Pfizer, Prometheus Biosciences, Reistone, Takeda, and Techlab Inc. Quera R and Nuñez F Phave received support for attending meetings from Janssen.
Figures




Similar articles
-
Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice.Curr Gastroenterol Rep. 2016 Jan;18(1):5. doi: 10.1007/s11894-015-0477-6. Curr Gastroenterol Rep. 2016. PMID: 26759147 Review.
-
Review on Advances in Pediatric Endoscopy in the Management of Inflammatory Bowel Disease.Curr Pediatr Rev. 2025;21(2):154-165. doi: 10.2174/0115733963268547231128101929. Curr Pediatr Rev. 2025. PMID: 38265388 Review.
-
Endoscopy in inflammatory bowel disease: Role in diagnosis, management, and treatment.World J Gastroenterol. 2018 Sep 21;24(35):4014-4020. doi: 10.3748/wjg.v24.i35.4014. World J Gastroenterol. 2018. PMID: 30254405 Free PMC article. Review.
-
Inflammatory bowel diseases: controversies in the use of diagnostic procedures.Dig Dis. 2009;27(3):269-77. doi: 10.1159/000228560. Epub 2009 Sep 24. Dig Dis. 2009. PMID: 19786751 Review.
-
Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American Society for Gastrointestinal Endoscopy IBD Endoscopy Consensus Panel.Gastrointest Endosc. 2025 Feb;101(2):295-314. doi: 10.1016/j.gie.2024.08.034. Epub 2024 Oct 18. Gastrointest Endosc. 2025. PMID: 39425706
Cited by
-
Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy-A New Potential Therapeutic Target in Inflammatory Bowel Disease.Diagnostics (Basel). 2023 Mar 24;13(7):1230. doi: 10.3390/diagnostics13071230. Diagnostics (Basel). 2023. PMID: 37046447 Free PMC article. Review.
-
CD73 blockade alleviates intestinal inflammatory responses by regulating macrophage differentiation in ulcerative colitis.Exp Ther Med. 2023 Apr 21;25(6):272. doi: 10.3892/etm.2023.11972. eCollection 2023 Jun. Exp Ther Med. 2023. PMID: 37206543 Free PMC article.
-
Prediction of early mucosal healing of Crohn's disease after treatment with biologics- a novel nomogram based on radiomics and clinical risk factors.Front Pharmacol. 2025 May 23;16:1586300. doi: 10.3389/fphar.2025.1586300. eCollection 2025. Front Pharmacol. 2025. PMID: 40487394 Free PMC article.
-
Diagnostic Methods and Biomarkers in Inflammatory Bowel Disease.Diagnostics (Basel). 2025 May 22;15(11):1303. doi: 10.3390/diagnostics15111303. Diagnostics (Basel). 2025. PMID: 40506875 Free PMC article. Review.
-
Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers?Mar Drugs. 2024 Jul 25;22(8):336. doi: 10.3390/md22080336. Mar Drugs. 2024. PMID: 39195452 Free PMC article. Review.
References
-
- Loftus EV Jr. Crohn's Disease: Etiology, Complications, Assessment, Therapy, and Management. Gastroenterol Clin North Am. 2017;46:xiii–xixv. - PubMed
-
- Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, Calabrese E, Baumgart DC, Bettenworth D, Borralho Nunes P, Burisch J, Castiglione F, Eliakim R, Ellul P, González-Lama Y, Gordon H, Halligan S, Katsanos K, Kopylov U, Kotze PG, Krustinš E, Laghi A, Limdi JK, Rieder F, Rimola J, Taylor SA, Tolan D, van Rheenen P, Verstockt B, Stoker J European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13:144–164. - PubMed
-
- Zilli A, Capogreco A, Furfaro F, Allocca M, Roda G, Loy L, Fiorino G, Danese S. Improving quality of care in endoscopy of inflammatory bowel disease: can we do better? Expert Rev Gastroenterol Hepatol. 2020;14:819–828. - PubMed
-
- Vatn MH. Natural history and complications of IBD. Curr Gastroenterol Rep. 2009;11:481–487. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical